Revenio Group Oyj

Director's Dealing • Feb 19, 2024

Revenio Group Corporation: Managers' Transactions – Tomi Karvo

Revenio Group Corporation | Stock Exchange Release | February 19, 2024 at 15:00:00 EET

Person subject to the notification requirement Name: Tomi Karvo Position: Other senior manager

Issuer: Revenio Group Oyj LEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATION Reference number: 52795/5/4

Transaction date: 2024-02-15 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009010912 Nature of transaction: DISPOSAL

Transaction details (1): Volume: 5 Unit price: 29.02 EUR (2): Volume: 2 Unit price: 29 EUR (3): Volume: 104 Unit price: 29 EUR (4): Volume: 300 Unit price: 28.98 EUR (5): Volume: 20 Unit price: 29.02 EUR (6): Volume: 31 Unit price: 29 EUR (7): Volume: 5 Unit price: 29.06 EUR (8): Volume: 36 Unit price: 28.98 EUR (9): Volume: 117 Unit price: 28.98 EUR

Aggregated transactions (9): Volume: 620 Volume weighted average price: 28.98668 EUR

For further information, please contact

CFO Robin Pulkkinen, tel. +358 50 505 9932 robin.pulkkinen@revenio.fi

Distribution

Nasdaq Helsinki FIN-FSA Key media www.reveniogroup.fi

Revenio Group in brief

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand.

In 2023, the Group's net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Tomi Karvo